These findings suggest that strategies aimed at mitigating ferroptosis, such as activating and upregulating the GPX4 pathway, may offer promising therapeutic avenues for ALS (Wang et al., 2022). This evidence concerns the gene GPX4 and amyotrophic lateral sclerosis.